General Stock Ideas

[ombowstring]

gfp, I wonder if PolyMedix's Brilacidin might yet prove to be shown efficacious. It's not a pretty picture ((see below), but I thought that the science was theoretically plausible, a potential game-changer. It seems that no one is interested in the molecule, though. Maybe it was just another pie-in-the-sky Cortex. Poly needed a Big Pharma partner to fund the clinical trials, but the company's strategy was one of issuing more and more stock as the source revenues.

https://seekingalpha.com/article/4081348-innovation-pharmaceuticals-cellceutix-still-hopeless-still-worthless

>>>Innovation Pharmaceuticals (Cellceutix): Still Hopeless, Still Worthless

•IPIX has never been more financially vulnerable than today and is currently technically insolvent. IPIX already does not have the cash to run proper trials.

•New forensic background diligence into IPIX’s drug compounds shows a worthless collection of obsolete and already failed drugs acquired from defunct and bankrupt entities for virtually nothing.

•Large pharma companies must surely be aware of these old and recycled compounds? Tellingly, no credible pharma company bought IPIX’s core drugs for pennies despite them being available recently.

•Also, no pharma company has stepped forward with interest in partnering on a Phase 3 for any of IPIX’s assets despite the company endlessly discussing the prospect.

•IPIX trials are a waste of time and money with small patient samples. Insiders collect millions of dollars personally as they drag out the inevitable failure of their unviable drugs.

On June 7th, Cellceutix issued a press release detailing plans to change its name to the factually incorrect Innovation Pharmaceuticals (OTCQB:IPIX), along with a ticker change from CTIX to IPIX. On the following day, Cellceutix/Innovation Pharmaceuticals hosted a hype-filled conference call in which management essentially rehashed the company's failed development efforts while providing essentially nothing new of material substance.<<<